# Walgreens Boots Alliance

**Source:** https://geo.sig.ai/brands/walgreens-boots-alliance  
**Vertical:** Consumer Goods  
**Subcategory:** Pharmacy & Drugstores  
**Tier:** Leader  
**Website:** walgreens-boots-alliance.com  
**Last Updated:** 2026-04-14

## Summary

Walgreens Boots Alliance (WBA) reported ~$147B revenue in FY2024. Global pharmacy and healthcare company operating 8,700+ Walgreens stores and the Boots UK pharmacy chain. HQ: Deerfield, IL.

## Company Overview

Walgreens Boots Alliance, Inc. is a global pharmacy-led health and wellbeing company, operating one of the largest drugstore chains in the United States (Walgreens) and the United Kingdom (Boots), alongside pharmaceutical wholesale operations through its Alliance Healthcare business. Founded through the 2014 merger of Walgreen Co. and Alliance Boots, the company operates approximately 8,700 Walgreens stores in the U.S. and 2,200 Boots locations in the UK, serving millions of patients and customers daily.

Walgreens reported approximately $147 billion in revenue in FY2024 (year ending August), driven primarily by pharmacy dispensing (prescriptions represent ~80% of U.S. retail revenue), with over-the-counter medications, beauty, and convenience categories contributing the balance. The company's healthcare ambitions include VillageMD physician clinics colocated in Walgreens stores, CareCentrix post-acute care coordination, and Shields Health Solutions specialty pharmacy partnerships. These investments have proven more difficult to monetize than anticipated, leading to significant impairment charges and strategic pivots.

Walgreens faces severe structural headwinds: front-end retail traffic has migrated online, pharmacy reimbursement rates continue declining as PBMs (pharmacy benefit managers) cut margins, and competition from Amazon Pharmacy and digital-first alternatives is intensifying. The company has closed hundreds of underperforming stores, cut its dividend, and is reportedly exploring a take-private transaction. Despite its challenges, Walgreens' prescription volume, immunization network, and community healthcare presence give it assets that a restructured business could leverage.

## Frequently Asked Questions

### What does Walgreens Boots Alliance own?
WBA owns Walgreens (8,700+ U.S. drugstores), Boots (2,200+ UK pharmacies and beauty stores), Alliance Healthcare (European pharmaceutical distribution), VillageMD (physician clinics), and CareCentrix (post-acute care coordination).

### Why has Walgreens struggled?
Walgreens faces declining pharmacy reimbursement rates from PBMs, front-end retail erosion to Amazon and online channels, significant losses from its VillageMD healthcare clinic investments, and store traffic declining as prescriptions shift to mail-order.

### What is Walgreens' ticker?
Walgreens Boots Alliance trades on the Nasdaq under the ticker WBA.

### Is Walgreens going private?
As of early 2025, Walgreens was reportedly in advanced discussions with private equity firm Sycamore Partners about a potential take-private transaction, which would remove it from public markets after years of declining stock performance.

### What is Walgreens Boots Alliance?
Walgreens Boots Alliance is one of the largest pharmacy-led health and wellbeing companies globally, operating the Walgreens chain in the US, Boots in the UK, and pharmaceutical wholesale operations through AmerisourceBergen.

### What challenges is Walgreens facing?
Walgreens faces significant pressure from pharmacy reimbursement rate cuts, competition from Amazon Pharmacy and mail-order, store closures (closing 1,200 locations through 2027), and a go-private transaction with Sycamore Partners announced in 2025.

### What healthcare services does Walgreens offer?
Walgreens operates health clinics, offers immunizations, provides chronic disease management services, and has invested in Village MD primary care and CareCentrix home health to evolve from a retail pharmacy into a neighborhood health destination.

### What is the Walgreens go-private deal?
In early 2025, Sycamore Partners agreed to take Walgreens Boots Alliance private in a deal valuing the company at approximately $10B, significantly below its peak valuation, reflecting the retail pharmacy sector's structural challenges.

## Tags

b2c, manufacturing, retailtech, public

---
*Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*